Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS with 1 % BSA and 0.09 % sodium azide
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C
Date de péremption
12-24 months
Lam, Yan, Xu, U, Cheng, Ho: "Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma." dans: Oncogenesis, Vol. 8, Issue 3, pp. 18, (2019) (PubMed).
Lam, Li, Xu, Leung, U, Zheng, Cheng, Ho: "Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts." dans: Respiratory research, Vol. 18, Issue 1, pp. 80, (2018) (PubMed).
Lam, U, Li, Xu, Cheng, Ho: "Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models." dans: Oncology reports, Vol. 40, Issue 4, pp. 1994-2004, (2018) (PubMed).
Xu, Lam, Cheng, Ho: "Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer." dans: Cancer science, Vol. 109, Issue 11, pp. 3471-3482, (2018) (PubMed).
McCallen, Prybylski, Yang, Lai: "Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O Backbone." dans: ACS biomaterials science & engineering, Vol. 3, Issue 8, pp. 1605-1615, (2017) (PubMed).